“…Endovascular treatment (EVT) has generally been the procedure of choice for older school-age, adolescent, and adult patients with native coarctation and those with recurrent coarctation. [10,11] As expected, surgical treatment is more invasive. It may cause complications such as bleeding, wound infection, re-coarctation, systemic hypertension, aortic aneurysm formation, endocarditis, premature coronary atherosclerosis, aorto-bronchial or aorto-esophageal fistulas and pain as well as a faulty cosmetic appearance at the incision site.…”
Coarctation of the aorta (CoA) forms 6-8% of congenital heart diseases (CHD). This narrowing typically occurs in the proximal descending aorta, close to the insertion of the patent ductus arteriosus and can be found with a number of concomitant diseases. CoA is a common cause of secondary arterial hypertension in young adults. Although CoA can be an isolated CHD, it is also commonly found in other congenital syndromes and cardiovascular anomalies. Herein this review paper we reported a brief history of management of aortic coarctation, and current treatment modalities concentrated on stent placement supported with two novel cases.
“…Endovascular treatment (EVT) has generally been the procedure of choice for older school-age, adolescent, and adult patients with native coarctation and those with recurrent coarctation. [10,11] As expected, surgical treatment is more invasive. It may cause complications such as bleeding, wound infection, re-coarctation, systemic hypertension, aortic aneurysm formation, endocarditis, premature coronary atherosclerosis, aorto-bronchial or aorto-esophageal fistulas and pain as well as a faulty cosmetic appearance at the incision site.…”
Coarctation of the aorta (CoA) forms 6-8% of congenital heart diseases (CHD). This narrowing typically occurs in the proximal descending aorta, close to the insertion of the patent ductus arteriosus and can be found with a number of concomitant diseases. CoA is a common cause of secondary arterial hypertension in young adults. Although CoA can be an isolated CHD, it is also commonly found in other congenital syndromes and cardiovascular anomalies. Herein this review paper we reported a brief history of management of aortic coarctation, and current treatment modalities concentrated on stent placement supported with two novel cases.
“…Since the first surgical repair of CoA in early 1940s by Dr. Crafoord, surgery remains a major treatment option for patients of all age group with CoA [38]. In neonates and young infants surgery is widely accepted as initial intervention of choice for significant CoA [18].…”
Section: Reviewmentioning
confidence: 99%
“…Further subclavian flap repair compromises limb development but does not repair in perceptible functional limitations [41]. Overall, surgical mortality after CoA repair is fairly low [38]. Immediate postoperative course may be complicated by paradoxical hypertension, recurrent laryngeal nerve injury, bleeding, subclavian steal, residual coarctation, etc.…”
Coarctation of aorta (CoA) is a discrete narrowing in aorta causing obstruction to the flow of blood. It accounts for 6–8% of all congenital heart diseases. With advances in fetal echocardiography rate of prenatal diagnosis of coarctation of aorta has improved but it still remains a challenging diagnosis to make prenatally. Transthoracic echocardiography is mainstay of making initial diagnosis and routine follow-up. Cardiac magnetic resonance imaging (MRI) and computed tomography (CT) are great advanced imaging tools for two-dimensional and three-dimensional imaging of aortic arch in complex cases. Based on type of coarctation, size of patient, severity of lesion, and associated abnormalities various management options like surgical treatment, transcatheter balloon angioplasty and transcatheter stent implantation are available. There is significant improvement in long-term survival from pre-surgical era to post-surgical era. But, among the postsurgical era patients, the long-term survival has not significantly changed between older and contemporary cohort. Patients with coarctation of aorta need lifelong follow-up event after successful initial intervention.
“…However, stent placement has replaced balloon angioplasty as the procedure of choice in older children and adults with native coarctation [66]. Currently, balloon dilatation and stenting remain the transcatheter interventions that can be used for the treatment of CoA [63,67]. Although balloon angioplasty was the treatment of choice for discrete native coarctation in adults in the past, most centers currently perform stent implantation for older children and adults with native discrete or long-segment coarctation.…”
The manuscript will discuss the epidemiology and etiology of the adult with coarctation of the aorta (CoA) as well as describe the embryology, anatomy, pathophysiology, and clinical presentation in order to recognize and appropriately diagnose an adult patient with CoA. This chapter will also review diagnostic testing, management, therapeutic interventions including percutaneous and surgical procedures, and long-term complications that can arise in an adult with repaired CoA. It contains images with examples from echocardiography, cardiac computed tomography (CT), magnetic resonance imaging (MRI), and angiograms as part of the description.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.